Long-term survival outcomes with Nivolumab (Nivo) in patients with previously treated advanced non-small cell lung cancer (NSCLC): Impact of early disease control and response

被引：0
|
作者：
Wohlleber, M. [1 ]
Brahmer, J. [2 ]
Borghaei, H. [3 ]
Ramalingam, S. S. [4 ]
Horn, L. [5 ]
de Castro Carpeno, J. [6 ]
Pluzanski, A. [7 ]
Burgio, M. A. [8 ]
Garassino, M. [9 ]
Chow, L. Q. M. [10 ]
Gettinger, S. [11 ]
Crino, L. [7 ]
Planchard, D. [12 ]
Butts, C. [13 ]
Drilon, A. [14 ]
Wojcik-Tomaszewska, J. [15 ]
Otterson, G. [16 ]
Agrawal, S. [17 ]
Li, A. [17 ]
Penrod, J. R. [17 ]
Antonia, S. J. [18 ]
机构：
[1] Robert Bosch Ctr Tumorerkankungen RBCT, Dept Pneumol Oncol, Gerlingen, Germany
[2] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[3] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[4] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[5] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[6] Ctr Integral Oncol Clara Campal, Madrid, Spain
[7] Inst Marii Sklodowskiej Curie, Ctr Onkol, Klin Nowotworow Pluca & Klatki Piersiowej, Warsaw, Poland
[8] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCSS, Med Oncol Unit, Meldola, Italy
[9] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
[10] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA USA
[11] Yale Canc Ctr, New Haven, CT USA
[12] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[13] Cross Canc Inst, Dept Oncol, Div Med Oncol, Edmonton, AB, Canada
[14] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[15] Wojewodzkie Ctr Onkol, Gdansk, Poland
[16] Ohio State Univ, Columbus, OH 43210 USA
[17] Bristol Myers Squibb, Princeton, NJ USA
[18] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P406
引用
收藏
页码：110 / 110
页数：1
相关论文
共 50 条
  • [41] Obesity Is Associated with Long-Term Improved Survival in Definitively Treated Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
    Lam, Vincent K.
    Bentzen, Soren M.
    Mohindra, Pranshu
    Nichols, Elizabeth M.
    Bhooshan, Neha
    Vyfhuis, Melissa
    Feigenberg, Steven J.
    Edelman, Martin
    Feliciano, Josephine L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S451 - S451
  • [42] Outcomes of nivolumab (NIVO)-treated patients (pts) with advanced non-small cell lung cancer (aNSCLC) in United States community oncology practice.
    Nadler, Eric
    Espirito, Janet
    Wilson, Thomas
    Gupte-Singh, Komal
    Rao, Sumati
    Korytowsky, Beata
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [43] Impact of Immune-Related Adverse Events on Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Nivolumab
    Ricciuti, B.
    Genova, C.
    De Giglio, A.
    Brambilla, M.
    Bassanelli, M.
    Dal Bello, M. G.
    Baglivo, S.
    Metro, G.
    Grossi, F.
    Chiari, R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S390 - S391
  • [44] Advanced non-small cell Lung Cancer (NSCLC) Nivolumab in advanced NSCLC with Squamous Epithelial Histology
    Sankawa, Yuri
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (03) : 149 - 149
  • [45] Long-term survival and health-related quality of life with nivolumab for previously-treated advanced non-small cell lung cancer (NSCLC): A wide prospective French real-world study (EVIDENS)
    Barlesi, F.
    Dixmier, A.
    Debieuvre, D.
    Raspaud, C.
    Auliac, J. B.
    Nicolas, B.
    Bombaron, P.
    Moro-Sibilot, D.
    Audigier-Valette, C.
    Asselain, B.
    Dumanoir, J.
    Cotte, F-E.
    Allan, V.
    Calvet, C.
    Reynaud, D.
    Perol, M.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1026 - S1026
  • [46] Impact of third-line chemotherapy on long-term survivors of advanced non-small cell lung cancer (NSCLC)
    Kim, T
    Kim, S
    Park, S
    Paek, J
    Choi, I
    Kim, D
    Kim, T
    Heo, D
    Bang, Y
    Kim, N
    [J]. LUNG CANCER, 2005, 49 : S252 - S253
  • [47] A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab
    Botticelli, Andrea
    Salati, Massimiliano
    Di Pietro, Francesca Romana
    Strigari, Lidia
    Cerbelli, Bruna
    Zizzari, Ilaria Grazia
    Giusti, Raffaele
    Mazzotta, Marco
    Mazzuca, Federica
    Roberto, Michela
    Vici, Patrizia
    Pizzuti, Laura
    Nuti, Marianna
    Marchetti, Paolo
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (1)
  • [48] Response to chemotherapy as a predictor of survival in advanced non-small cell lung cancer (NSCLC)
    Soussi, Ghassen
    Racil, Hajer
    Bacha, Saoussen
    Rouhou, Sana Cheikh
    Zidi, Asma
    Ayadi, Aida
    Chaouch, Nawel
    Chabbou, Abdellatif
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [49] A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab
    Andrea Botticelli
    Massimiliano Salati
    Francesca Romana Di Pietro
    Lidia Strigari
    Bruna Cerbelli
    Ilaria Grazia Zizzari
    Raffaele Giusti
    Marco Mazzotta
    Federica Mazzuca
    Michela Roberto
    Patrizia Vici
    Laura Pizzuti
    Marianna Nuti
    Paolo Marchetti
    [J]. Journal of Translational Medicine, 17
  • [50] PROGNOSTIC FACTORS FOR LONG-TERM SURVIVAL IN NON-SMALL CELL LUNG CANCER PATIENTS WITH INTERSTITIAL LUNG DISEASE
    Jeon, Jaehyun
    Kim, Young Tae
    Hwang, Yoohwa
    Kim, Hye Sun
    Park, In Kyu
    Kang, Chang Hyun
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S167 - S168
12345